Pharma/Biotech – USA, Europe Regulatory News, Oct 2023 Vol. 1
USA
FDA Draft Guidance Pushes for Development of Stimulant Use Disorder Treatments
With no FDA drug approvals to date for stimulant use disorder, the FDA has published draft guidance outlining...
Biotech Regulatory News, Combination Products, EU Regulatory News, Marketing Authorisation, Pharma Regulatory News, Regulatory News, USA Regulatory News